wcmedia.ru


Ginkgo Biotech Stock

TD Cowen Cuts Price Target on Ginkgo Bioworks to $3 From $7, Maintains Outperform Rating · Goldman Sachs Trims Ginkgo Bioworks Price Target to $ From $ Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform is market agnostic and enables biotechnology applications across diverse markets, from food. Ginkgo Bioworks Announces Participation in William Blair's 42nd Annual Growth Stock Conference. May 18, Ginkgo Bioworks and First Serv Announce Plans to. View the DNA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Ginkgo Bioworks Holdings. See the latest DNA Stock price for Ginkgo Bioworks Holdings Inc and NYSE: DNA stock Biotechnology. Stock Style Box: Small Core. Total Number of Employees.

What is Ginkgo Bioworks Holdings Inc(DNA)'s stock price today? The current price of DNA is $ The 52 week high of DNA is $ and 52 week low is $ Our cell programming platform enables the growth of biotechnology across diverse markets, from food to fragrance to pharmaceuticals. Ginkgo has also actively. Get Ginkgo Bioworks (DNA:NYSE) real-time stock quotes, news, price and financial information from CNBC. Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform is market agnostic and enables biotechnology applications across diverse markets, from. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $ billion in It raised $ million. Ginkgo Bioworks Holdings Inc. Class A ; Bid. ; Bid Size. ; VWAP. View the latest Ginkgo Bioworks Holdings Inc. (DNA) stock price, news, historical charts, analyst ratings and financial information from WSJ. Get the latest Ginkgo Bioworks Holdings Inc. Class A (DNA) stock price, news, buy or sell recommendation, and investing advice from Wall Street. View the DNA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Ginkgo Bioworks Holdings.

As of March 08, , Ginkgo Bioworks Holdings Inc had a $ billion market capitalization, putting it in the 72nd percentile of companies in the Biotechnology. DNA | Complete Ginkgo Bioworks Holdings Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Ginkgo Bioworks Holdings Stock Smart Score ; Analyst Consensus. Hold. Average Price Target: $ (% Upside) ; Blogger Sentiment. Bullish. DNA Sentiment 62%. Ginkgo Bioworks Holdings Inc. Class A (DNA) Stock Performance ; S&P BSE Sensex · , , , ; S&P Small-Cap · , , , Get the latest Ginkgo Bioworks Holdings Inc (DNA) real-time quote, historical performance, charts, and other financial information to help you make more. Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform is market agnostic and enables biotechnology applications across diverse markets. Key Data ; 52 Week High/Low, $/$ ; Market Cap, 2,,, ; Forward P/E 1 Yr. ; Earnings Per Share(EPS), $ ; Annualized Dividend, N/A. Real-time Price Updates for Ginkgo Bioworks Hldgs Inc (DNA-N), along with buy or sell indicators, analysis, charts, historical performance, news and more. Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform is market agnostic and enables biotechnology applications across diverse markets, from food.

Real time Ginkgo Bioworks (DNA) stock price quote, stock graph, news & analysis. Ginkgo Bioworks Holdings's market cap is calculated by multiplying DNA's current stock price of $ by DNA's total outstanding shares of 2,,, © These two biotech stocks could deliver life-altering returns for long-term investors. George Budwell. Cathie Wood is a big believer in the genomics revolution. Ginkgo Bioworks Holdings runs under Biotechnology sector within Health Care industry. The entity has B outstanding shares of which M shares are.

canadian exchange rate for today | ffin mobile app

5 6 7 8 9

Copyright 2016-2024 Privice Policy Contacts SiteMap RSS